Tissue Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR562805 |
| Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR562761 |
| Kidney Cancer Tissue Microarray | HIF2α targeted RNAi therapeutic inhibits clear cell renal cell carcinoma | Mol. Cancer Ther.2017, 2017 Oct | Tissue | CT565907 |
| Large cell carcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget, 2017 Mar | tissue | CP565586 |
| Large cell carcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget, 2017 Mar | tissue | CP565534 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS809425 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS705545 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS709226 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS711415 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS711728 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS712499 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS804723 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS805117 |
| Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol., 2019 May | Tissue | CS807036 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR559232 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR559715 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR561521 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR562036 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR562331 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR560083 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR560771 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR560135 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR562426 |
| Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine, 2019 Nov | Tissue | CR561778 |
| Lung Cancer | Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization | Nat Commun, 2018 Nov | Tissue | CT565899 |
| Lung Cancer | N-glycan structures of human alveoli provide insight into influenza A virus infection and pathogenesis | FEBS J., 2018 Mar | Tissue | CB610551 |
| Lung Cancer | Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p | Mol. Carcinog., 2017 Jul | Tissue | CP565586 |
| Lung Cancer | Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p | Mol. Carcinog., 2017 Jul | Tissue | CP565534 |
| Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square, 2020 Jun | Tissue | CP565585 |
| Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square, 2020 Jun | Tissue | CP565542 |
| Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square, 2020 Jun | Tissue | CP565443 |
| Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square, 2020 Jun | Tissue | CR559346 |
| Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square, 2020 Jun | Tissue | CR560789 |
| Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square, 2020 Jun | Tissue | CR562469 |
| LYPD6B | Doublecotin-like kinase 1 increases chemoresistance of colorectal cancer cells through the anti-apoptosis pathway | bioRxiv, 2019 Jan | Tissue | CT116 |
| Muscle RNA | Myocilin Stimulates Osteogenic Differentiation of Mesenchymal Stem Cells through Mitogen-activated Protein Kinase Signaling | J. Biol. Chem., Jun 2013; 288: 16882 - 16894., 2013 Jun | Tissue | |
| Nephritis, tubulointerstitial, chronic | Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions | EBioMedicine, 2021 Jan | Tissue | CS700464 |
| Nephritis, tubulointerstitial, chronic | Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions | EBioMedicine, 2021 Jan | Tissue | CS705284 |
| Normal | Identification and quantification of DNA repair protein poly(ADP ribose) polymerase 1 (PARP1) in human tissues and cultured cells by liquid chromatography/isotope-dilution tandem mass spectrometry | DNA Repair (Amst.) 2019, 2019 Mar | Tissue | CP565394 |
| Normal | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv, 2018 May | Tissue | CR559173 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR562944 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR561460 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR560086 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR559748 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR560906 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR560658 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR559696 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR561775 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR559241 |
| Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget, 2018 May | Tissue | CR559708 |
Germany
Japan
United Kingdom
China